Abstract
Primary cultured bovine brain microvessel endothelial cells (BBMECs), were used as an in vitro model of the blood-brain barrier to examine the involvement of eicosanoids in the permeability and cytoskeletal structural changes observed following exposure to tumor necrosis factor-α (TNF-α). Compared with control monolayers, BBMECs exposed to TNF-α formed actin filament tangles and extracellular gaps with a resultant increase in permeability. Both the permeability and cytoskeletal changes observed with TNF-α were significantly reduced following pretreatment with NS-398 or indomethacin, inhibitors of cyclooxygenase (COX). Western blot analysis showed that TNF-α had no apparent effect on the expression of COX-1, but did induce the expression of COX-2 in the BBMECs. The induction of COX-2 expression occurred within the same time frame (2–4 h following TNF-α exposure) as the permeability increases observed with the cytokine. Consistent with the increased expression of COX-2, BBMEC monolayers exposed to TNF-α had significantly greater secretion and release of prostaglandin E2 (PGE2) and prostaglandin F2α (PGF2α). Furthermore, BBMEC monolayers treated with PGE2 or PGF2α showed significant increases in permeability and cytoskeletal structural changes when compared with control monolayers. Together, these results suggest that the TNF-α-induced permeability and cytoskeletal structural effects are due, in part, to an induction of the COX-2 system and increased release of prostaglandins in the cerebral microvasculature.
Footnotes
-
Send reprint requests to: Dr. Donald W. Miller, University of Nebraska Medical Center, College of Pharmacy, Department of Pharmaceutical Science, 986025 Nebraska Medical Center, Omaha, NE 68198-6025. E-mail: DWMILLER{at}unmc.edu
-
This work was supported by National Institutes of Health Grant R29 NS36831-01; by the American Association of Colleges of Pharmacy; and by the American Heart Association, Nebraska Affiliate, Predoctoral Fellowship 9804123S (to K.S.M.).
- Abbreviations:
- TNF-α
- tumor necrosis factor-α
- AIDS
- acquired immune deficiency syndrome
- BBB
- blood-brain barrier
- PG
- prostaglandin
- COX
- cyclooxygenase
- BBMEC
- bovine brain microvessel endothelial cell
- BSA
- bovine serum albumin
- BCA
- bicinchoninic acid
- FDX
- fluorescein-conjugated dextran
- PBS
- phosphate-buffered saline
- DPBS
- Dulbecco's phosphate-buffered saline
- NF-κB
- nuclear factor-κB
- LPS
- lipopolysaccharide
- Received July 24, 2000.
- Accepted February 21, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|